The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
Sign in to access this content
Sign InAmid positive assessments of growth and profitability within the insurance sector, Piper Sandler has raised its price target for Globe Life (GL) from $175 to $200 while maintaining an Overweight rating. According to reports, this bullish revision comes despite significant insider selling activity totaling $30.8 million over the past three months. The move underscores analyst confidence in the company's operational trajectory and its ability to deliver shareholder value in the coming period.
Looking at peer performance, MetLife's recent results showed an 8% year-over-year growth in operating earnings, bolstering the broader outlook for the life insurance industry (per recent quarterly filings). Market data indicates that Globe Life holds a GF Score of 85/100, a metric reflecting strong historical financial performance relative to peers, even as some investors weigh concerns regarding current valuation multiples.
GL shares closed at $178.99 (close July 14, 2026), suggesting an upside potential of approximately 11% to reach the new target. Investors are now monitoring key US economic catalysts that could impact financial sector sentiment, including Initial Jobless Claims and a scheduled speech by the Fed's Williams later this week.